We came across a bullish thesis on Stepan Company on Danny’s Substack’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on SCL. Stepan Company’s share was trading at $66.

Stepan Company (NYSE:SCL) is included among the 13 Most Promising Long-Term Stocks to Buy According to Hedge Funds. On February 23, Stepan Company (NYSE:SCL) announced Project Catalyst, which is a ...

Stepan Company's 2025 results show early signs of operational recovery—6% EBITDA growth, reduced net debt, and positive FCF in 4Q25. Read why SCL stock is a Buy.

CFO Ruben Velasquez stated, “Fourth quarter 2025 adjusted net loss was $0.5 million or down $0.02 per diluted share. Reported net income was $5 million, up 49% versus prior year, primarily reflecting ...

SCL Health is a nonprofit healthcare organization that operates eight hospitals and more than 100 service centers. With net revenues of $2.54 billion, SCL provides more than $222 million a year in ...